Mycoplasma pneumoniae has been recognized to be involved in several extra-pulmonary diseases, but the underlying immunologic mechanisms are still largely unknown. Recently, we observed a significant elevation of serum Immunoglobulin E (IgE) in a small group of these children. Here, we assessed total serum IgE levels in children affected with Mycoplasma pneumoniae-related extra-pulmonary diseases.
INTRODUCTION
Mycoplasma pneumoniae (M. pneumoniae) has emerged as a common respiratory pathogen in children M. pneumoniae respiratory infections have been associated to asthma exacerbations. 1 Interestingly, M. pneumoniae infection has been related to the onset of several extra-respiratory diseases, too. Actually, non-respiratory disorders sometimes represent the most evident clinical manifestations of M. pneumoniae infection: indeed, it is often limited to the upper respiratory tract (leading to mild symptoms only) and, therefore, can remain completely unnoticed. 2 Most clinical descriptions of extra-pulmonary manifestations due to M. pneumoniae are skin (urticarial rashes, multiform erythema, StevensJohnson syndrome, nodular erythema, etc.) and joints (reactive arthritis/arthralgia) diseases. However, several clinical disorders, affecting nervous, heart, gastrointestinal, hematological systems, have been related to M. pneumoniae infection, as well. 3 Unfortunately, despite the growing number of clinical reports describing M. pneumonia-related extrapulmonary diseases, the pathogenesis is still elusive. Probably, several pathologic changes in the respiratory tract induced by M. pneumoniae are mediated by the innate and adaptive immune response, in addition to a direct pathogenic effect of this infectious agent. Similarly, extra-pulmonary diseases have been supposed to be triggered by M. pneumoniae through immune-mediated mechanisms in predisposed individuals, maybe because of their genetic background and/or concomitant environmental factors. [3] [4] [5] [6] [7] Recently, by observing a small group of children diagnosed with different M. pneumoniae-related extrapulmonary diseases, we noticed a common and simple immunological alteration, namely a significant elevation of total serum immunoglobulin E (IgE). 8 Based upon this finding, we decided to analyze serum IgE levels in children admitted to the hospital because of clinical syndromes being consistent with M. pneumoniae infection, in order to confirm the aforementioned data in a larger cohort of patients.
MATERIALS AND METHODS

Patients and Study Design
Pediatric Figure 1 .
Only 11 children reported a previous diagnosis of environmental allergy (made by skin prick tests) at the admission: among those, 6 were in group I, 4 in group II and only 1 in group III. Moreover, also the presence of recurrent respiratory infections (RRI) was investigated at the admission: interestingly, 12 children with RRI were in group I and other 9 were in group II, but none was reported in group III.
Increased total Serum Immunoglobulin E in Children with M. Pneumoniae-related Extrapulmonary Diseases
Serum IgE levels have been calculated and expressed as mean value  standard deviation [MSD] for each group of patients. There was no significant difference of total serum IgE between children with M. pneumoniae respiratory infections and those with airways infections caused by non-mycoplasma infectious agents (253.5256.8 UI/mL vs. 164.3748.3 UI/mL, respectively). On the contrary, patients developing M. pneumoniae-related extra-pulmonary diseases showed significantly higher level of IgE than both previous groups (402.1594.7 UI/mL; p<0.001 vs. group I; p<0.01 vs. group II), as showed in Figure 2 .
The difference of mean age between group II and group III (that was not significant statistically, anyway) may have an analytical effect on the difference of total serum IgE among the study groups. Therefore, we tried reducing the potential effect of patients' age on serum IgE levels, by comparing the absolute value of total serum IgE in each patient with the correspondent upper limit of reference values for age. In Figure 3 , the relative increase of total serum IgE was expressed as percentage of the upper limit of the reference values (single patient's IgE absolute value/upper limit of IgE reference value for age x 100). Based upon this calculation, group III showed a 516261% (MSD) increase of total serum IgE compared to normal value for age, which resulted to be significantly higher than group II (MSD: 22369%, p<0.05).
DISCUSSION
M. pneumoniae is primarily an extracellular pathogen, needing tight cell contact for survival. Although in vitro studies showed that some species, including M. pneumoniae, are able to penetrate cell membranes and invade culture cells, the cytotoxic effect can be simply mediated by its adherence to host cells, (through the release of enzymatic and lytic metabolites directly on the cell surface). [10] [11] [12] However, the most relevant pathologic damages to humans are probably mediated by the host immune response, leading to the production of inflammatory mediators both in respiratory and extra-respiratory tissues, as suggested by several in vivo and in vitro studies. [13] [14] [15] [16] Indeed, many interleukins (IL) have been found to be altered in serum of patients affected with M. pneumoniae infections. In particular, extrapulmonary diseases have been supposed to be reactive disorders arising in immunologically predisposed individuals.
12,17
Several studies analyzed the immunologic response in respiratory infections caused by M. pneumoniae and also its potential role in pediatric asthma. 18, 19 M.
pneumoniae has been showed to promote airway inflammation, by eliciting the production of several cytokines (such as interferon [IFN]-, IL-1, IL-2, IL-6 and tumor necrosis factor [TNF]-) and suppressing others. Therefore, the balance among multiple cytokines during M. pneumoniae infection may play a significant role in the development of respiratory complications, such as severe pneumonia and/or asthma.
20-22
The prevalent generation of Th2 immune responses and inflammation may promote pediatric asthma during M. pneumoniae infection. 23 Total and specific IgE responses have been described during M. pneumoniae respiratory infections, as well as in several viral and bacterial airways infections. 24, 25 However, despite atopy is considered a risk factor to develop asthma in children, actually there is no evidence supporting a prominent specific IgE response during respiratory infections due to M. pneumoniae or in the complicated clinical forms. 26, 27 In this regard, several interesting findings emerged from our clinical study. First, M. pneumoniae-related and clinically relevant diseases resulted to affect older children than those developing respiratory infections caused by other infectious agents. That observation is in agreement with previous clinical data from the medical literature: although M. pneumoniae resulted to be a common respiratory pathogen in children <5 years, actually lower airways infections, pneumonia and complications were reported to be more frequent in school-aged children (from 5 to 15 years of age). 28, 29 Recently, a study by Sun H et al. supported the concept that younger infants with M. pneumoniae infection usually have a milder clinical course than older children. 30 Indeed, in our case series, the median age of children with M. pneumoniae-unrelated respiratory infections was <3 years and, thus, significantly younger than the age of children requiring hospital admission for relevant or complicated respiratory infections due to M. pneumoniae. Moreover, such a result was valid for both pulmonary and extra-pulmonary diseases caused by M. pneumoniae. According to these findings, we might suppose that the age of clinically relevant M. pneumoniae diseases is older because previous contacts with this agent might be required, providing a kind of immunological imprinting to predisposed patients. Probably, the main result of this study is that hospitalized children diagnosed with different M. pneumoniae-related extra-pulmonary diseases showed significantly increased serum IgE, compared to children developing respiratory illnesses only.
As mentioned above, a recent study found significantly higher circulating levels of several cytokines (such IL-6, IL-10 and IFN-γ), IgA, and percentages of CD8 + cells, in patients with refractory M. pneumoniae-related pulmonary infections. 31 Moreover, some studies indicated that several cytokines, including IL-8, IL-9, IL-10, IL-17, IL-18 and IFN-γ, could modulate pulmonary lesions during M. pneumoniae respiratory infections. 16, 22 On the contrary, pathological and immunologic mechanisms of extra-pulmonary diseases triggered by this infectious agent are still unveiled and our findings might be a starting point to improve this knowledge.
Very recently, we described a case series of 5 children with different extra-respiratory complications of M. pneumoniae infection. Interestingly, all showed an elevation of total serum IgE, as a common immunologic feature. 8 In this study, we confirmed this observation in a wider cohort of children, as in the group with extrapulmonary diseases total serum IgE levels resulted to be significantly higher than in children with classical respiratory infections due to M. pneumoniae. Moreover, such a difference was maintained also by evaluating this biological parameter in a relative manner, namely as a percentage increase compared to the upper reference limit specific for age.
Of course, our study has several limitations due to the loss of some statistical units, the limited number and the absence of randomization, as being an observational study. However, it might prompt further experimental validation in experimental and more controlled study settings.
In conclusion, we might speculate that atopy might be a biological marker of predisposition to develop extra-pulmonary complications during M. pneumoniae infection. According to some recent observations, atopy may be related to some potential and concomitant immune mechanisms in autoimmune diseases, such as basophil-dependent (self-reactive) IgE and IL-17 production. [32] [33] [34] Probably, IgE plays no direct role in the pathogenesis of these clinical manifestations, but the immune imprinting to produce IgE (and, particularly, the cellular processes and cytokine environment underlying the individual atopic constitution), might trigger a number of different mechanisms, leading to the heterogeneous spectrum of clinical disorders described in association to M. pneumoniae infection.
